Scientists from the National Institutes of Health (NIH) published a framework in the New England Journal of Medicine this week for efforts to increase the number, quality and type of daily tests for SARS-CoV-2, the virus that causes COVID-19, to 6 million by the end of 2020.
This has taken the... Read More »
The U.S. Senate’s 2021 National Defense Authorization Act (NDAA) includes legislation that
would help the Cybersecurity and Infrastructure Security Agency (CISA) warn the owners and operators of critical infrastructure computer systems that it is vulnerable to cyberattacks.
The bill gives... Read More »
A new agreement reached between Bavarian Nordic A/S and AdaptVac for 4 million euros upfront will allow Bavarian to license AdaptVac’s capsid virus like particle (cVLP) technology for coronaviruses.
Of particular note here is that the agreement gives Bavarian global commercialization rights to... Read More »
The House of Representatives’ recent unanimous vote to extend the Chemical Facility Anti-Terrorism Standards program (CFATS) has garnered plaudits from lawmakers and chemical industry organizations.
CFATS is the nation’s first regulatory program focusing specifically on security at high-risk... Read More »
A pair of lawmakers are espousing the benefits of the House of Representatives’ passage of the National Defense Authorization Act (NDAA) for FY21.
Reps. Mac Thornberry (R-TX) and Adam Smith (D-WA), chairman of the House Armed Services Committee, offered statements regarding the... Read More »
A new program -- the National Testing Implementation Forum -- announced by the United States Department of Health and Human Services (HHS) this week will gather input from private stakeholders across the U.S. to inform federal testing and diagnostics efforts for SARS-CoV-2, the virus that causes... Read More »
The Coalition for Epidemic Preparedness (CEPI) has extended a call for proposals on COVID-19 vaccines until September, pushing for licensure, efficacy and safety in quick order: a timeframe of just 12-18 months.
The coalition is working to guarantee that manufacturing capabilities and capacities... Read More »
A federal grand jury in Spokane, Wash., indicted two hackers from the People’s Republic of China for alleged cyberattacks on hundreds of computer systems of companies, governments, non-governmental organizations, and individuals in the United States and abroad.
Officials alleged the global... Read More »
Up to 600 million doses of a vaccine candidate produced by Pfizer Inc. and BioNTech could be acquired by the United States government under a deal penned this week.
All of this would be conditional on the vaccine’s successful manufacture and either Emergency Use Authorization or licensure... Read More »
U.S. Reps. Jim Langevin (D-RI) and Mike Gallagher (R-WI), commissioners of the Cyberspace Solarium, applauded the inclusion of budget amendments to the 2021 National Defense Authorization Act (NDAA) that implement recommendations from the Solarium Commission’s report.
The Cyberspace Solarium... Read More »
Republican committee leaders in the U.S. House of Representatives are urging the Trump administration to impose consequences on China-linked hackers who have targeted U.S. institutions, including sanctions.
“We applaud your administration’s work to ramp up the investigation and prosecution... Read More »
First Responder Network Authority (FirstNet) officials said the high-speed broadband communications platform dedicated to first responders has expanded across North Carolina as a means of advancing public safety communications.
“FirstNet is a dedicated broadband platform for public safety, by... Read More »
Sens. Mike Enzi (R-WY) and Maggie Hassan (D-NH) introduced Monday legislation targeting potentially harmful counterfeit medical products while also protecting patients from such dangers.
The Safeguarding Therapeutics Act would empower the Food and Drug Administration (FDA) to seize and destroy... Read More »
CureVac and GlaxoSmithKline plc (GSK) have signed an agreement to work together on the research, development, manufacturing, and marketing of as many as five mRNA-based vaccines and monoclonal antibodies for use against infectious diseases.
By collaborating, CureVac gains access to GSK’s mRNA... Read More »
